Recent OTC articles

Posted Aug 25, 2009

Consumers around the world have cut back on a range of discretionary purchases to conserve cash.  One area where some Canadians have reduced spending is non-prescription medications, with a quarter of those surveyed changing their buying habits in this category, according to a recent report from The Nielsen Company.  Steps Canadians are taking include using over-the-counter (OTC) meds less frequently (26%), using less than the recommended dosage (13%), buying smaller quantities (10%) or cutting them out altogether (4%). 
As a whole, Canadians are more likely to wait out minor illnesses and …

[read more]
Posted Jan 26, 2009

Over-the-counter (OTC) heartburn medications save the U.S. healthcare system $757 million each year — by reducing office visits, Nielsen and the Consumer Healthcare Products Association (CHPA) reported in a study released on January 26th.
At an individual level, OTC heartburn remedies save the average American $174 each year — in office visits and medication costs.
Nielsen and CHPA’s joint study also found that 94% of all patients report being satisfied with available OTC heartburn medications.
More than half (61%) of consumers surveyed by Nielsen and CHPA reported treating their heartburn without discussing symptoms with …

[read more]
Posted Dec 23, 2008

The launch of Zyrtec OTC and its private label equivalent, Private Label Cetirizine, in early 2008 triggered strong incremental growth in the over-the-counter (OTC) allergy medication market in the U.S., a new analysis by NielsenHealth and Wolters Kluwer Health reports.
According to Nielsen and Wolters Kluwer, the OTC oral/nasal allergy market grew by about 30% in the first half of 2008, compared with same period in 2007.
Like Zyrtec OTC, PL Cetirizine had rapid uptake, accounting for approximately one-third of the OTC cetirizine market’s patient volume during the spring 2008 allergy season.  Zyrtec …

[read more]
Posted Nov 11, 2008

Zyrtec isn’t the first prescription drug to make the switch to over-the-counter (OTC) availability.  But when McNeil launched the OTC version of its allergy medication in January 2008, Zyrtec’s prescription-to-OTC transition was hardly “typical,” according to a new analysis by NielsenHealth and Wolters Kluwer Health.
In the first six months following its launch (January to June 2008), Zyrtec OTC shook up prescription and OTC allergy medication markets in the U.S.   Prescription allergy drug sales declined sharply, while over-the-counter allergy drug sales increased significantly.
By June 2008, prescription sales of Zyrtec had declined to nearly …

[read more]
Posted Oct 27, 2008

Still more data confirming the battered state of the U.S. economy: U.S. consumers are more price conscious than shoppers in other countries — even when their health is on the line.
According to a global survey conducted by Nielsen and the Association of the European Self-Medication Industry (AESGP), U.S. consumers place more importance on price and value when choosing over-the-counter (OTC) medications than consumers in other countries throughout Europe, Asia Pacific, North America, and the Middle East. 
Thirty percent of U.S. consumers consider price to be important when choosing OTC products, while …

[read more]